197P ATREZZO trial (SOLTI-1907): A phase II trial targeting estrogen receptor negative or PAM50 non-luminal disease with atezolizumab in combination with trastuzumab and vinorelbine in HER2-positive (HER2+) advanced breast cancer (ABC) - Interim analysis
Titel:
197P ATREZZO trial (SOLTI-1907): A phase II trial targeting estrogen receptor negative or PAM50 non-luminal disease with atezolizumab in combination with trastuzumab and vinorelbine in HER2-positive (HER2+) advanced breast cancer (ABC) - Interim analysis
Auteur:
Ciruelos, E.M. Ortega, P. Tolosa Bofill, F.J. Salvador González-Santiago, S. Miro, C.R. Albacar Escrivá-De-Romaní, S. Gonzalez, A. Lopez Simon, S. Pernas Ponce, J. Martínez-Sáez, O. Cejalvo, J.M. Martorell, A. Perello López-Barajas, I. Blancas Guerra, J.A. Torres, E. Sanfeliu Sanchez, C.A. Rodríguez Villanueva, L. Villacampa, G. Prat, A. Pascual, T.